Professor Kevin Harrington - The Institute of Cancer Research, London
Cancer survival 'to double in 10 years' - PressReader
Higher Scientific Officer - Targeted Therapy Team, Prof Kevin Harrington (ID496) at The Institute of Cancer Research
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust
Professor Kevin Harrington - The Institute of Cancer Research, London
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE
Professor Kevin Harrington - The Institute of Cancer Research, London
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
ICR Postdoc Association (PDA) (@Postdocs_ICR) / Twitter
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London
Scientific Lecture | Kevin Harrington | FRONTAL
Cancer: Scientists aim to double survival within a decade | The Independent
Oracle Research Event 2019 Kevin Harrington: Radiotherapy - YouTube
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Get A-Head Visit The Institute of Cancer Research - Get Ahead
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
_kevin-harrington-embed.jpg?sfvrsn=70547b69_2 "Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London")
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
SAB and I-O AB - T3 Pharma
Scientists reveal new lines of attack to raise cancer survival rate | Cancer research | The Guardian
